Skip to main content
SpringerLink
Log in
Book cover

CNS Complications of Malignant Disease pp 306–323Cite as

Palgrave Macmillan

Chemical Markers in Spinal Fluid for Tumours of the Central Nervous System (CNS)

  • Chapter

Abstract

Until recently the accurate diagnosis and assessment of malignant disease in the central nervous system (CNS) has been costly and time-consuming. The advent of computerised axial tomography (CT scanning) has resulted in a major change in policy in many neurological units, but the technique is not yet generally available. Moreover, and in common with most other methods of diagnosis, CT scanning is limited by its inability to reflect the degree of viability of the solid or fluid lesions which are visualised.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abelev, G. (1971). Alpha feto-protein in ontogenesis and its association with malignant tumours. Adv. Cancer Res., 14, 295.

    Article  PubMed  CAS  Google Scholar 

  • Allen, J. P., Kendall, J. W., McGilvra, R. and’Vancura, C. (1974). Immunoreactive ACTH in cerebrospinal fluid. J. clin. Endocr. Metab., 38, 586.

    Article  PubMed  CAS  Google Scholar 

  • Allen, N. and Reagan, E. (1964). Beta-glucuronidase activities in cerebrospinal fluid. Archs Neurol., 11, 144.

    Article  CAS  Google Scholar 

  • Bagshawe, K. D. and Harland, S. (1976). Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system. Cancer, 38, 112.

    Article  PubMed  CAS  Google Scholar 

  • Bagshawe, K. D. (1976). Risk and prognostic factors in trophoblastic neoplasia. Cancer, 38, 1373.

    Article  PubMed  CAS  Google Scholar 

  • Bagshawe, K. D. (1977). In G. Mathe (ed), Treatment of trophoblastic tumours. Recent Results in Cancer Research p. 192. Springer-Verlag.

    Google Scholar 

  • Barone, A. (1948). L’attivita lisozimica attuale del liquor nelle malatti nervose. Acta Neurol. Italia, 3, 434.

    Google Scholar 

  • Braunstein, G. D., McIntire, K. R. and Waldmann, T. A. (1973). Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas. Cancer, 31, 1065.

    Article  PubMed  CAS  Google Scholar 

  • Brightman, M. W., Klatzo, I., Olsson, Y. and Reese, T. S. (1970). The blood-brain barrier to proteins under normal and pathological conditions. J. nurol. Sei., 10, 215.

    Article  CAS  Google Scholar 

  • Clausen, J. (1961). Proteins in normal cerebrospinal fluid not found in serum. Proc. Soc. exp. Biol. Med., 107, 170.

    Article  PubMed  CAS  Google Scholar 

  • Dude, B. G. M., Salmon, S. E. and Russell, D. H. (1977). Polyamines as markers of response and disease activity in cancer chemotherapy. Cancer Res., 37, 214.

    Google Scholar 

  • Fleisher, J. H., Marton, L. J., Bachur, N. R. and Mann-Kaplan, R. S. (1973). Cholesterol in cerebrospinal fluid of brain tumour patients. Life Sci., 13, 1517.

    Article  PubMed  CAS  Google Scholar 

  • Frithz, G., Ericsson, P. and Ronquist, G. (1977). Adenylate kinase activity in cerebrospinal fluid in connection with transitory ischaemic attacks. Uppsala J. Med., 82, 11.

    Article  CAS  Google Scholar 

  • Fumagalli, M. D. and Paoletti, P. (1971). Sterol test for human brain tumours: relationship with different oncotypes. Neurology, 21, 1149.

    Article  PubMed  CAS  Google Scholar 

  • Haghbin, M., Tan, C. T. C., Clarkson, B. D., Mike, V. and Burchenal, J. H. (1975). Treatment of acute lymphoblastic leukaemia in children with ‘prophylactic’ intrathecal methotrexate and intensive chemotherapy. Cancer Res., 35, 807.

    PubMed  CAS  Google Scholar 

  • Hildebrand, J. (1973). Early diagnosis of brain metastases in an unselected population of cancerous patients. Eur. J. Cancer, 9, 621.

    Article  PubMed  CAS  Google Scholar 

  • Hildebrand, J. and Levin, S. (1973). Enzymatic activities in cerebrospinal fluid in patients with neurological diseases. Acta Neurol. Belg., 73, 229.

    PubMed  CAS  Google Scholar 

  • Houck, J. C., McBride, H. J. and O’Doherty, D. S. (1968). The value of cerebrospinal fluid glycoprotein levels in the diagnosis of primary brain tumour. Neurology, 18, 397.

    Article  PubMed  CAS  Google Scholar 

  • Jordan, R. M., Kendall, J. W., Senich, J. L., Allen, J. P., Paulsen, C. A., Kerber, C. W. and Vanderlaan, W. P. (1976). Cerebrospinal fluid hormone concentra-tions in the evaluation of pituitary tumours. Ann. intern. Med., 85, 49.

    Article  PubMed  CAS  Google Scholar 

  • Kardana, A. and Bagshawe, K. D. (1976). A rapid, sensitive and specific radio-immunoassay for human chorionic gonadotrophin. J. immunol. Meth., 9, 297.

    Article  CAS  Google Scholar 

  • Kubinski, H. and Javid, M. (1973). Proteins from human cerebrospinal fluid: binding with nucleic acids. Science, 182, 296.

    Article  PubMed  CAS  Google Scholar 

  • Laterre, E. C., Heremans, J. F. and Carbonaza, A. (1964). Immunological comparison of some proteins found in cerebrospinal fluid, urine and extracts from brain and kidney. Clin. Chim. Acta, 10, 197.

    Article  PubMed  CAS  Google Scholar 

  • Linfoot, J. A., Garcia, J. F., Wei, W., Fink, R., Sarin, R., Born, J. L. and Lawrence, J. H. (1970). Human growth hormone levels in cerebrospinal fluid. J. clin. Endocr. Meta and, 31, 230.

    Article  CAS  Google Scholar 

  • Long, D. M. (1970). Capillary ultrastructure and the blood-brain barrier in human malignant brain tumour. J. Neurosurg., 32, 127.

    Article  PubMed  CAS  Google Scholar 

  • Marton, L. J., Hely, O., Levin, V. A., Lubich, W. P., Crafts, D. C. and Wilson, C. B. (1976). The relationship of polyamines in cerebrospinal fluid to the presence of central nervous system tumours. Cancer Res., 36, 973.

    PubMed  CAS  Google Scholar 

  • Newlands, E. S., Dent, J., Kardana, A., Searle, F. and Bagshawe, K. D. (1976). Serum alpha-fetoprotein and H. C. G. in patients with testicular tumours. Lancet, ii, 744.

    Google Scholar 

  • Paoletti, P., Vandenheuvel, F. A., Fumagalli, R. and Paoletti, R. (1969). The sterol test for the diagnosis of human brain tumours. Neurology, 19, 190.

    Article  PubMed  CAS  Google Scholar 

  • Reitamo, S. and Klockars, M. (1976). Lysozyme activity in cerebrospinal fluid. Acta Med. Scand., 199, 321.

    Article  PubMed  CAS  Google Scholar 

  • Rennert, O. M., Lawson, D. L., Shukla, J. B. and Miale, T. D. (1977). Cerebrospinal fluid polyamine monitoring in central nervous system leukaemia. Clin. Chim. Acta, 75, 365.

    Article  PubMed  CAS  Google Scholar 

  • Ronquist, G., Frithz, G., Ericsson, P. and Hugosson, R. (1977). Malignant brain tumours associated with adenylate kinase in cerebrospinal fluid. Lancet, i, 1284.

    Google Scholar 

  • Ruoslahti, E. and Seppala, M. (1972). Alpha-fetoprotein in normal human serum.Nature, 235, 161.

    CAS  Google Scholar 

  • Schroeder, L. L., Johnson, J. C. and Malarkey, W. B. (1976). Cerebrospinal fluid prolactin: a reflection of abnormal prolactin secretion in patients with pituitary tumours. J. clin. Endocr. Metab., 43, 1255.

    Article  PubMed  CAS  Google Scholar 

  • Smith, J. A., Francis, T. I., Edington, G. M. and Williams, A. O. (1971). Human alpha fetoprotein in body fluids. Br. J. Cancer, 25, 337.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Stiffel, M., Dittmann, J., Faulhauer, K. and Loew, F. (1973). Enzymes in cerebrospinal fluid in normal samples, samples from patients with brain tumours, and other neurological diseases. Wien Z. Nervenheilkd., 31, 325.

    CAS  Google Scholar 

  • Weber, E. L. (1972). Electrophoretic analysis of cerebrospinal fluid proteins in patients with central nervous system mass lesions. J. Neurosurg., 36, 679.

    Article  PubMed  CAS  Google Scholar 

  • Weiss, J. F., Ransohoff, J. and Kayden, H. J. (1972). Cerebrospinal fluid sterols in patients undergoing treatment for gliomas. Neurology, 22, 187.

    Article  PubMed  CAS  Google Scholar 

  • Weiss, R. R., Macri, J. M. and Elligers, K.W. (1976). Origin of amniotic fluid alpha-fetoprotein in normal and defective pregnancies. Obst. Gynec., 47, 697.

    CAS  Google Scholar 

Download references

Authors
  1. S. B. Kaye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. D. Bagshawe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Southampton General Hospital, UK

    J. M. A. Whitehouse (Director of the CRC Medical Oncology Unit) (Director of the CRC Medical Oncology Unit)

  2. Royal Marsden Hospital, London, UK

    H. E. M. Kay (Consultant Haematologist) (Consultant Haematologist)

Copyright information

© 1979 S. B. Kaye and K. D. Bagshawe

About this chapter

Cite this chapter

Kaye, S.B., Bagshawe, K.D. (1979). Chemical Markers in Spinal Fluid for Tumours of the Central Nervous System (CNS). In: Whitehouse, J.M.A., Kay, H.E.M. (eds) CNS Complications of Malignant Disease. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-04285-2_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-04285-2_29

  • Publisher Name: Palgrave Macmillan, London

  • Print ISBN: 978-1-349-04287-6

  • Online ISBN: 978-1-349-04285-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation